Moreover, TLR3 and -9 activation has been demonstrated to reduce tumor growth in renal cell carcinoma and metastatic colorectal cancer [16,17] Besides those data that demonstrate favorable effects of TLR activation it is known that TLR ligands can also promote cancer cell survival, migration and tumor progression. This evidence concerns the gene TLR3 and metastatic colorectal cancer.